Sabra(SBRA) ZACKS·2025-02-19 23:31分组1 - Sabra Healthcare reported quarterly funds from operations (FFO) of $0.36 per share, matching the Zacks Consensus Estimate, and an increase from $0.33 per share a year ago [1] - The company posted revenues of $182.35 million for the quarter ended December 2024, which was 0.48% below the Zacks Consensus Estimate, but an increase from $163.4 million year-over-year [2] - Over the last four quarters, Sabra has surpassed consensus FFO estimates three times and topped consensus revenue estimates three times [2] 分组2 - The stock has underperformed, losing about 5% since the beginning of the year, while the S&P 500 gained 4.2% [3] - The current consensus FFO estimate for the coming quarter is $0.37 on revenues of $185.38 million, and for the current fiscal year, it is $1.49 on revenues of $762.45 million [7] - The Zacks Industry Rank for REIT and Equity Trust - Other is currently in the bottom 34% of over 250 Zacks industries, indicating potential challenges for the sector [8]